Riken Institute To Consider With Authors STAP Study Retractions
This article was originally published in PharmAsia News
Executive Summary
Japan's Riken institute plans discussions with researchers about retracting the stimulus-triggered acquisition of pluripotency papers they published, its president said, based on questions about reliability and research ethics.